We are speaking with physicians about the surge in patient interest in peptides such as BPC-157, TB-500, and mitochondrial peptides sourced online. We are looking for brief, experience-based insights on how this is showing up in clinical practice and how you counsel patients. Short quotes are welcome. 1. What trends are you seeing in how patients are sourcing and using these peptides? 2. What risks or complications have you encountered, including contamination, dosing variability, or adverse effects? 3. How do you guide patients toward safer, evidence-based alternatives when they request these compounds?